RxDoctor Payments Data
★ My doctorsLook up a doctor →

Ravi Srinivasa, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1134333768

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 67.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $55,044 and has fallen 85.7% since, to $7,887 in 2025. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$130,456in general payments, 2019–2025

Across 239 payments — averaging $545.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$88K
  • Microvention, Inc.$21K
  • Siemens Medical Solutions USA, Inc.$13K
  • Medtronic$3K
  • Penumbra, Inc.$3K
  • Biocompatibles, Inc.$949
  • plus $2K from 13 others
$148,735in research payments, 2019–2025

Across 46 payments — averaging $3233.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$99K
  • Boston Scientific$50K

What the payments were for

  • Consulting fees$31,00824%
  • Speaking & faculty fees$67,91352%
  • Travel & lodging$23,50118%
  • Food & beverage$8,0356%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific134$87,787
Microvention, Inc.9$20,929
Siemens Medical Solutions USA, Inc.30$13,453
Medtronic(2 entities)34$2,751
Penumbra, Inc.11$2,580
Biocompatibles, Inc.2$949
W. L. Gore & Associates, Inc.2$513
Guerbet LLC1$500
Angiodynamics, Inc.2$174
Bard Peripheral Vascular, Inc.2$125
Dova Pharmaceuticals1$125
Johnson & Johnson1$119
AbbVie1$118
Musculoskeletal Transplant Foundation Inc.1$114
Cook Medical LLC3$99
Terumo Medical Corporation2$39
Inari Medical, Inc.1$38
Sirtex Medical Inc1$25
Stryker1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$130,456 in reported general payments places this provider in the 90th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024
$158,726
Medicare patients
303
Services billed
3,883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →